Key result
COVID-19 myocarditis yields ~84% recovery in reported adult cases, with mortality driven by shock or ARDS.
Why the study?
Cardiac injury occurs in approximately 30% of COVID-19 infections and can present as myocarditis, prompting a review to summarise current evidence on this complication.
Systematic Review (n=70)
COVID-19-related myocarditis carries a risk of sudden clinical worsening, highlighting the need for healthcare workers to recognize its clinical presentation.
Clinicians should monitor COVID-19 myocarditis for shock or ARDS; leaves open true incidence and prognosis due to case-report bias.
Despite the progress of its management, COVID-19 maintains an ominous condition which constitutes a threat, especially for the susceptible population. The cardiac injury occurs in approximately 30% of COVID-19 infections and is associated with a worse prognosis. The clinical presentation of cardiac involvement can be COVID-19-related myocarditis. Our review aims to summarise current evidence about that complication. The research was registered at PROSPERO (CRD42022338397). We performed a systematic analysis using five different databases, including i.a. MEDLINE. Further, the backward snowballing technique was applied to identify additional papers. Inclusion criteria were: full-text articles in English presenting cases of COVID-19-related myocarditis diagnosed by the ESC criteria and patients over 18 years old. The myocarditis had to occur after the COVID-19 infection, not vaccination. Initially, 1588 papers were screened from the database search, and 1037 papers were revealed in the backward snowballing process. Eventually, 59 articles were included. Data about patients' sex, age, ethnicity, COVID-19 confirmation technique and vaccination status, reported symptoms, physical condition, laboratory and radiological findings, applied treatment and patient outcome were investigated and summarised. COVID-19-related myocarditis is associated with the risk of sudden worsening of patients' clinical status, thus, knowledge about its clinical presentation is essential for healthcare workers.
No takes yet. Share an insight, caveat, or question.
Urban et al. (2022) conducted a systematic review in COVID-19-related myocarditis (n=70). COVID-19-related myocarditis was evaluated. Among 70 published adult case reports of COVID-19-related myocarditis, recovery was achieved in 84% of patients with reported outcomes, while 17% died, often following complications such as cardiogenic shock or ARDS.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: